2008 Consumption Data Topical 
Cannabis Law Report
NOVEMBER 16, 2021
(“WM Technology” or the “Company”) (Nasdaq: MAPS), a leading technology and software infrastructure provider to the cannabis industry, has released its first data and insights report, titled ‘Cannabis in America’. Half (50%) of cannabis consumers said their consumption has increased since the start of the pandemic in March 2020.
PrestoDoctor
JUNE 11, 2019
The data comes from a short window of time but does indicate that legalization has little to no impact on youth usage. With cannabis, Being Adept focuses on a range of topics from concentrates and dabs to the significant changes in strain potency over the decades. New Approaches to Drug Education and Prevention. All Hands On Deck.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
JULY 24, 2022
In the 1970s, the use of psychedelics was banned due to political pressure and increasing (uncontrolled) consumption. It was not until the 1990s that psychedelics research was resumed, first with psilocybin and DMT, and since 2008 also with LSD. Data Bridge Market Research , (last viewed 13 July 2022). [2] billion by 2029. [1]
The Cannigma
JANUARY 13, 2023
Treating migraine pain is one of the instances where inhaled cannabis consumption, such as smoking or vaping , is important for the right effects and speed of delivery. Edibles won’t produce the same experience, but topicals may be able to help, too. Daily cannabis consumption was an effective treatment for 85% of participants.
Cannabis Law Report
NOVEMBER 24, 2021
At the same time, the outlook on cannabis research data is largely positive. 2018 ; Frankhauser 2008 ). It was also used as a topical treatment for haemorrhoids, ear infection, and wounds (Aldrich 1997 ; Touw 1981 ). Data collection. It also has an extensive and diverse history of medicinal use. 2016 ; Sznitman et al.
Cannabis Law Report
JULY 12, 2019
Regarding the warning for specific populations that based on animal data the pharmaceutical may cause fetal harm. There is sufficient data, as indicated in discussion, that inert ingredients within this newly approved CBD pharmaceutical for the US Market have already been proven to cause harm in the unborn fetus, and not the cannabinoid.
NORML
AUGUST 26, 2019
Furthermore, Virginia’s consumption/product regulations are smoke-free. While patients won’t be rolling up joints full of pungent flower, they can still access oils, tinctures, lozenges, inhalers, topicals, and pills packed with non-intoxicating CBD or THC-A, the acidic precursor of THC.
Expert insights. Personalized for you.
52 
Let's personalize your content